Hyperprolactinemia is a Major Problem in Patients Treated with Antipsychotic Drugs

被引：0
|
作者：
Baskoy, Kamil [1 ]
Ay, Seyid Ahmet [1 ]
Deniz, Ferhat [1 ]
Yonem, Arif [1 ]
机构：
[1] Haydarpasha Training Hosp, Gulhane Mil Med Fac, Dept Endocrinol & Metab, Istanbul, Turkey
来源：
KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY | 2016年 / 26卷 / 02期
关键词：
hyperprolactinemia; antipsychotic; endocrinology;
D O I：
10.5455/bcp.20151209125410
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：210 / 211
页数：2
相关论文
共 50 条
  • [41] MAJOR SIDE-EFFECTS OF ANTIPSYCHOTIC-DRUGS
    CHARALAMPOUS, KD
    KEEPERS, GA
    JOURNAL OF FAMILY PRACTICE, 1978, 6 (05): : 993 - 1002
  • [42] Psychiatric Patients with Antipsychotic Drug-Induced Hyperprolactinemia and Menstruation Disorders
    Takechi, Kenshi
    Yoshioka, Yurika
    Kawazoe, Hitoshi
    Tanaka, Mamoru
    Takatori, Shingo
    Kobayashi, Miwako
    Matsuoka, Ichiro
    Yanagawa, Hiroaki
    Zamami, Yoshito
    Imanishi, Masaki
    Ishizawa, Keisuke
    Tanaka, Akihiro
    Araki, Hiroaki
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2017, 40 (10) : 1775 - 1778
  • [43] How Hyperprolactinemia Affects Sexual Function in Patients Under Antipsychotic Treatment
    Rubio-Abadal, Elena
    Del Cacho, Nuria
    Saenz-Navarrete, Gerard
    Arranz, Belen
    Cambra, Rosa-Maria
    Cuadras, Daniel
    Rodante, Demian
    Feher, Csaba
    Roca, Mercedes
    Barneda, Vanessa
    Usall, Judith
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2016, 36 (05) : 422 - 428
  • [44] Hip fractures in patients treated with antipsychotic drugs. Study of retrospective cohorts in Catalonia
    Gonzalez Tejon, Susana
    Ibarra Jato, Montserrat
    Fernandez San Martin, M. Isabel
    Prats Uribe, Albert
    Real Gatius, Jordi
    Miguel Martin-Lopez, Luis
    ATENCION PRIMARIA, 2022, 54 (02):
  • [45] The effect of hypertension and obesity on the development of diabetes mellitus in patients treated with atypical antipsychotic drugs
    Sumiyoshi, T
    Roy, A
    Jayathilake, K
    Meltzer, HY
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2004, 24 (04) : 452 - 454
  • [46] Hyperprolactinemia in antipsychotic-naive patients with first-episode psychosis
    Riecher-Roessler, A.
    Rybakowski, J. K.
    Pflueger, M. O.
    Beyrau, R.
    Kahn, R. S.
    Malik, P.
    Fleischhacker, W. W.
    PSYCHOLOGICAL MEDICINE, 2013, 43 (12) : 2571 - 2582
  • [47] Increased metabolic risk in adolescents patients treated with atypical antipsychotic drugs: Preliminary results
    Cuerda Compes, C.
    Arango, C.
    Velasco, C.
    De Castro, M.
    Paron, L.
    Breton, I.
    Camblor, M.
    Garcia-Peris, P.
    SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 497 - 497
  • [48] Rapid reduction in hyperprolactinemia upon switching treatment to olanzapine from conventional antipsychotic drugs or risperidone
    Kinon, BJ
    Basson, B
    Wang, J
    Malcolm, SK
    SCHIZOPHRENIA RESEARCH, 2000, 41 (01) : 194 - 195
  • [49] Guidelines for Antipsychotic-Induced Hyperprolactinemia
    Miyamoto, Brigitta E.
    Galecki, Martha
    Francois, Dimitry
    PSYCHIATRIC ANNALS, 2015, 45 (05) : 266 - 272
  • [50] The Use of Antipsychotic Drugs in Patients with Dementia
    Protopopova, D.
    Masopust, J.
    Valis, M.
    Hort, J.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2015, 78 (02) : 158 - 162
12345